The Government Says These Medicines Could Pose Health Risks
The Indian government has taken another step towards improving the safety of medicines. The Ministry of Health & Family Welfare has banned the manufacture, sale, and distribution of 16 Fixed-Dose Combination (FDC) drugs with immediate effect after an expert review found that these medicines have no scientific support or no real benefit to the patients.
What are Fixed Dose Combinations (FDC) Drugs?
Fixed-Dose Combination drugs are medications that contain 2 or more active pharmaceutical ingredients in a single tablet, capsule, syrup, or cream. These combinations are often developed to make a treatment easier by reducing the number of medicines a patient needs to take.
Many FDCs are widely used and accepted around the world, but every combination must have strong scientific evidence that shows that the ingredients work well together and provide better results than taking the medicines separately.
If a combination has no clear medical advantage or increases the chances of side effects, then it is considered an irrational FDC.
Why are these 16 drugs banned?
The decision is made after a detailed review that was ordered by the Supreme Court of India. An expert committee under the Drugs Technical Advisor Board (DTAB) examined several fixed-dose combinations available in the market.
After studying the available clinical data, the committee concluded that these 16 combinations did not have a benefit to the patient, while some could even increase the health risks.
Based on these findings, the government of India used its power under Section 26A of the Drugs and Cosmetics Act to ban them with immediate effect
The banned combinations belong to different treatment categories, including:
Antibiotic Combinations, Pain-Relief Medicines, Antispasmodic Drugs, Anti-Diabetic Formulations, Skin and Dermatology Products.
The list of banned combinations
- Amoxicillin + Serratiopeptidase
- Amoxicillin + Cloxacillin + Lactic Acid Bacillus + Serratiopeptidase
- Amoxicillin + Serratiopeptidase + Lactobacillus Sporogenes
- Cefuroxime + Serratiopeptidase
- Cefadroxyl + Probenecid
- Gliclazide + Chromium Picolinate
- Paracetamol + Lignocaine
- Dicyclomine + paracetamol + Clidinium Bromide
- Dicyclomine + paracetamol + Clidinium Bromide + Chlordiazepoxide
- Acetyl Salicylic Acid + Ethoheptazine
- Aloe Extract + Allantoin + Alpha Tocopherol Acetate + D-Panthenol + Vitamin A
- Aloe Extract + Vitamin E + Dimethicone + Glycerine
- Aloe vera + Jojoba Oil + Vitamin E
- Aloe vera + Orange Oil
- Aloe vera + Jojoba Oil + Wheat Germ Oil + Tea Tree Oil
- Aloe Vera + Vitamin E + Herbal preparation
The government says that the aim is to make sure that only medicines that are backed by scientific evidence remain available in the market.
Over the years, India has taken action against several irrational FDCs, as experts believe that unnecessary combinations can expose patients to side effects, which make treatment more expensive and even contribute to problems like antibiotic resistance when antibiotics are combined without a proper medical need.
Removing such products from the market encourages the use of medicines that have been properly studied and proven to be effective and safe.
Conclusion
The ban on these 16 fixed-dose combination drugs is another step towards making the medicines safer and more effective for patient access in India.
While the decision might affect manufacturers and some healthcare practices, its main purpose is to ensure that patients receive treatments that are supported by science and offer real health benefits
